Silverarc Capital Management »

Humana shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Humana (HUM) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Humana

Tip: Access up to 7 years of quarterly data

All positions including Humana held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humana by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.9M 10k 486.52

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Humana

Vanguard Group
Wellington Management Company
T. Rowe Price Associates
Citadel Advisors
Jpmorgan Chase & Co
Norges Bank Investment Management
Newport Trust
Bank of America Corporation
Legal & General Group
Sanders Capital
Starboard Value
Dimensional Fund Advisors
Millennium Management
Franklin Resources
Bank of New York Mellon

View all funds holding Humana